$QTI

QT IMAGING HOLDINGS, INC. (QTI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Chief Executive Officer Restricted Stock Unit Grant On August 28, 2026, the Board of Directors (the “ Board ”) of QT Imaging Holdings, Inc. (the “ Company ”), upon the recommendation of the Compensation Committee of the Board, approved a grant to Dr. Dinu, under the Com

QT Imaging Holdings (QTI) reported Q2 2026 revenue of $7.4 million, up 103% year over year, driven by 15 scanner shipments. First-half revenue was $14 million. Fiscal 2026 guidance calls for about $39 million revenue. Q2 gross margin was 41%; operating loss $1.9 million and net loss $11.1 million. Company extended debt to 2029 and raised $10 million via an offering.

QT IMAGING HOLDINGS, INC. (QTI) filed an SEC Form 8-K — Results of Operations and Financial Condition. QT Imaging Delivers Strong Second Quarter Growth While Building the Foundation for Commercial Scale Second-quarter revenue reached $7.4 million; first-half revenue increased 116% to $14.0 million, with 28 scanners shipped Strengthened capital position through a $10.0 million publ

QT IMAGING HOLDINGS, INC. (QTI) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. qti-20260728 false 0001844505 3 Hamilton Landing Suite 160 Novato CA 94949 415 842-7250 QTI 0001844505 2026-07-28 2026-07-28 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________ FORM 8-K ________________________________

QT Imaging Holdings, Inc. announced its financial results for the fourth quarter and full year ended December 31, 2025, reporting record full-year revenue of $18.9 million, exceeding guidance, and shipping 40 scanners. The company affirmed its 2026 revenue guidance of approximately $39 million, driven by distributor partnerships and the QTI Cloud Platform. Key achievements include FDA clearance for an updated scanner configuration, approval of a new Category III CPT code for its Breast Acoustic CT, and significant financial strengthening through a private placement.

QT Imaging Holdings, Inc. announced the first commercial sale of its QTI Breast Acoustic CT™ System to True Health Center for Functional Medicine, following a strategic distribution partnership. This innovative system aims to improve breast imaging by eliminating compression, radiation, and the need for contrast agents, focusing on patient comfort and safety. The technology, validated by the National Institutes of Health, provides high-quality 3D images and addresses limitations of traditional methods, especially for dense breast tissue.

QT Imaging Holdings (QTI) has released a new investor presentation detailing supplemental product and operational information, including its FDA-cleared QT Breast Scanner. The presentation aims to manage investor expectations by providing regulatory context, financial metrics, and extensive risk disclosures. Spark, TipRanks' AI Analyst, rates QTI as "Neutral" due to weak financial performance tempered by recent positive corporate updates.

QT Imaging Holdings, Inc. (QTIH) has announced a partnership with Olea Medical to integrate advanced visualization, quantitative analytics, and AI-ready imaging capabilities into QT Imaging's cloud-based SaaS platform. This collaboration aims to enhance clinical interpretation, support research workflows, and enable advanced quantitative imaging analysis, particularly in breast imaging. The integration is expected to strengthen QT Imaging's position by offering a comprehensive, cloud-based platform that combines its acoustic imaging technology with established radiology tools and analytics.